Apyx Medical's top three insider shareholders as of June 18, 2026 are Andrew Makrides (Ceo, 624.39K shares), Moshe Citronowicz (Senior Vice President, 493.50K shares), Charles D. Ii Goodwin (Chief Executive Officer, 90.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Matthew C Hill | Chief Financial Officer | 7,836 | 0 | 13 Aug, 2024 |
| Andrew Makrides | Ceo | 624,389 | 0 | 11 Jul, 2022 |
| Moshe Citronowicz | Senior Vice President | 493,504 | 0 | 17 Mar, 2026 |
| Michael Geraghty | - | 27,500 | 0 | 08 Jun, 2023 |
| Lawrence Waldman | - | 37,563 | 0 | 11 Jul, 2022 |
| Charles D. Ii Goodwin | Chief Executive Officer | 90,000 | 0 | 15 Nov, 2023 |
| Craig A. Swandal | - | 17,000 | 0 | 21 Mar, 2022 |
| Shawn David Roman | Chief Operating Officer | 0 | 12,000 | 29 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Mar, 2026 | Moshe Citronowicz | Common Stock | A | 37,000 | $1.80 | 493,504 | D | M |
| 15 Mar, 2026 | Moshe Citronowicz | Common Stock | A | 37,000 | $1.80 | 493,504 | D | M |
| 15 Mar, 2026 | Moshe Citronowicz | Stock option (right to buy) | D | 37,000 | $0.00 | 0 | D | M |
| 15 Mar, 2026 | Moshe Citronowicz | Stock option (right to buy) | D | 37,000 | $0.00 | 0 | D | M |
| 27 Jan, 2026 | Shawn David Roman | Common Stock | A | 12,000 | $1.80 | 12,000 | I | M |
| 27 Jan, 2026 | Shawn David Roman | Common Stock | A | 12,000 | $1.80 | 12,000 | I | M |
| 27 Jan, 2026 | Shawn David Roman | Stock option (right to buy) | D | 12,000 | $0.00 | 0 | D | M |
| 27 Jan, 2026 | Shawn David Roman | Stock option (right to buy) | D | 12,000 | $0.00 | 0 | D | M |
| 15 May, 2025 | Charles D. Ii Goodwin | Stock Option (Option to Buy) | A | 193,000 | $0.00 | 193,000 | D | A |
| 15 May, 2025 | Moshe Citronowicz | Stock Option (Option to Buy) | A | 36,000 | $0.00 | 36,000 | D | A |
| 15 May, 2025 | Matthew C Hill | Stock Option (Option to Buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 15 May, 2025 | Moshe Citronowicz | Stock Option (Option to Buy) | A | 36,000 | $0.00 | 36,000 | D | A |
| 15 May, 2025 | Charles D. Ii Goodwin | Stock Option (Option to Buy) | A | 193,000 | $0.00 | 193,000 | D | A |
| 15 May, 2025 | Wendy Lauren Levine | Stock Option (Option to Buy) | A | 64,000 | $0.00 | 64,000 | D | A |
| 15 May, 2025 | Wendy Lauren Levine | Stock Option (Option to Buy) | A | 64,000 | $0.00 | 64,000 | D | A |
| 15 May, 2025 | Minnie Baylor-Henry | Stock Option (Option to Buy) | A | 59,000 | $0.00 | 59,000 | D | A |
| 15 May, 2025 | Lawrence Waldman | Stock Option (Option to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 15 May, 2025 | Stavros G. Vizirgianakis | Stock Option (Option to Buy) | A | 128,000 | $0.00 | 128,000 | D | A |
| 15 May, 2025 | Lawrence Waldman | Stock Option (Option to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 15 Jan, 2025 | Lawrence Waldman | Stock Option (Option to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |